Startseite
Personalized medicine as key to targeted therapy
The Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology (IKP) conducts research at the Bosch Health Campus on improving drug therapy. It is considered the largest scientific research unit in the field of clinical pharmacology in Germany and enjoys a high international reputation.
Our core tasks
Pharmacogenomics and implementation of the latest findings into clinics and practices
Identification of new drug targets, taking into account innovative -omics technologies for the individualization of drug therapy
Provision of state-of-the-art and high- end human model systems for drug research and therapy optimization
Clinical Trials
Clinical trials are of great importance for medical progress and are an indispensable part of being able to better assess the effectiveness and tolerability of drugs. This requires drug studies to be carried out with volunteers (= healthy study participants).